Erratum: Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats (European Journal of Pharmacology (2005) 506 (63-69) DOI: 10.1016/j.ejphar.2004.10.044);Interaction between 1,4-butanediol and ethanol on operant responding and the cardiovascular system

European Journal of Pharmacology

Volumn 506, Issue 1, 2004, Pages 75-82

  Gerak, Lisa R ^a   Hicks, Alissa R ^a   Winsauer, Peter J ^a   Varner, Kurt J ^a  

^a LOUISIANA STATE UNIV HLTH SCI C   (United States)

Author keywords

1,4 Butanediol; Heart rate; Mean arterial pressure; Radio telemetry; Rat; Schedule controlled behavior

Indexed keywords

1,4 BUTANEDIOL; 4 HYDROXYBUTYRIC ACID; ALCOHOL;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; CONSCIOUSNESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; FOOD; HEART RATE; HYPOTHESIS; INSTRUMENTAL CONDITIONING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECORDING; TELEMETRY;

EID: 9644282923     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.01.035     Document Type: Erratum

References (32)

1. M. Abramowicz Gamma Hydroxybutyrate (Xyrem) for Narcolepsy Med. Lett. Drugs Ther. vol. 44 2002 103 105
2. L.A. Badon, A. Hicks, K. Lord, B.A. Ogden, S. Meleg-Smith, and K.J. Varner Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of ecstasy J. Pharmacol. Exp. Ther. 302 2002 898 907
3. R. Bernasconi, P. Mathivet, S. Bischoff, and C. Marescaux Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Trends Pharmacol. Sci. 20 1999 135 141
4. S.P. Bessman, and E.R. McCabe 1,4-Butanediol-a substrate for rat liver and horse liver alcohol dehydrogenases Biochem. Pharmacol. 21 1972 1135 1142
5. D.C. Bird, F.A. Holloway, and J.M. Carney Schedule-controlled behavior as an index of the development and loss of ethanol tolerance in the rat Psychopharmacology (Berl) 87 1985 414 420
6. M. Blumenfeld, R.G. Suntay, and M.H. Harmel Sodium gamma-hydroxybutyric acid: a new anesthetic adjuvant Anesth. Analg. 41 1962 721 726
7. A.J. Boyd, I.A. Sherman, and F.G. Saibil The cardiovascular effects of gamma-hydroxybutyrate following hemorrhage Circ. Shock 38 1992 115 121
8. M.A. Carai, G. Colombo, R. Reali, S. Serra, I. Mocci, M.P. Castelli, G. Cignarella, and G.L. Gessa Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid Eur. J. Pharmacol. 441 2002 157 163
9. L.P. Carter, L.R. Flores, H. Wu, W. Chen, A.W. Unzeitig, A. Coop, and C.P. France The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies J. Pharmacol. Exp. Ther. 305 2003 668 674
10. L.P. Carter, A.W. Unzeitig, H. Wu, W. Chen, A. Coop, W. Koek, and C.P. France The Discriminative stimulus effects of gamma-hydroxybutyrate and related compounds in rats discriminating baclofen or diazepam: the role of GABA(B) and GABA(A) receptors J. Pharmacol. Exp. Ther. 309 2004 540 547
11. L.P. Carter, H. Wu, W. Chen, C.M. Cruz, R.J. Lamb, W. Koek, A. Coop, and C.P. France Effects of {gamma}-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors J. Pharmacol. Exp. Ther. 308 2004 182 188
12. Center for Disease Control Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate JAMA 265 1991 447 448
13. R.L. Chin, K.A. Sporer, B. Cullison, J.E. Dyer, and T.D. Wu Clinical course of gamma-hydroxybutyrate overdose Ann. Emerg. Med. 31 1998 716 722
14. L. Degenhardt, S. Darke, and P. Dillon GHB use among Australians: characteristics, use patterns and associated harm Drug Alcohol Depend. 67 2002 89 94
15. K.A. Eckermann, W. Koek, and C.P. France Chronic 1,4-butanediol treatment in rats: cross-tolerance to gamma-hydroxybutyrate and (+/-)-baclofen Eur. J. Pharmacol. 484 2004 259 262
16. Food and Drug Administration Warning about GHB JAMA 265 1991 1802
17. J. Friedman, R. Westlake, and M. Furman "Grievous bodily harm:" gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome Neurology 46 1996 469 471
18. D.E. Fuller, and C.S. Hornfeldt From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy Pharmacotherapy 23 2003 1205 1209
19. L. Gallimberti, G. Canton, N. Gentile, M. Ferri, M. Cibin, S.D. Ferrara, F. Fadda, and G.L. Gessa Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome Lancet 2 1989 787 789
20. C. Gomes, C. Flygt, M. Henning, L. Norin, T.H. Svensson, and G. Trolin Gammahydroxy butyric acid: cardiovascular effects in the rat J. Neural. Transm. 38 1976 123 129
21. A.R. Hicks, D.R. Kapusta, and K.J. Varner Mechanisms underlying the sympathomimetic cardiovascular responses elicited by g-hydroxybutyrate J. Cardiovasc. Pharmacol. 44 2004 000
22. R.J. Lamb, J. Munn, N.J. Duiker, A. Coop, H. Wu, W. Koek, and C.P. France Interactions of gamma-hydroxy butyrate with ethanol and NCS 382 Eur. J. Pharmacol. 470 2003 157 162
23. C. Lobina, R. Agabio, R. Reali, G.L. Gessa, and G. Colombo Contribution of GABA(A) and GABA(B) receptors to the discriminative stimulus produced by gamma-hydroxybutyric acid Pharmacol. Biochem. Behav. 64 1999 363 365
24. K.L. Nicholson, and R.L. Balster GHB: a new and novel drug of abuse Drug Alcohol Depend. 63 2001 1 22
25. B. Persson, and M. Henning Central cardiovascular effects of gamma-hydroxybutyric acid: interactions with noradrenaline, serotonin, dopamine and acetylcholine transmission Acta Pharmacol. Toxicol. (Copenh) 47 1980 335 346
26. B. Persson, and M. Henning Effect of GABA analogues on blood pressure and central GABA metabolism in the rat Acta Pharmacol. Toxicol. (Copenh) 47 1980 135 143
27. F. Poldrugo, and G. Addolorato The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies Alcohol Alcohol. 34 1999 15 24
28. F. Poldrugo, and O.C. Snead 1,4-Butanediol and ethanol compete for degradation in rat brain and liver in vitro Alcohol 3 1986 367 370
29. F. Poldrugo, S. Barker, M. Basa, F. Mallardi, and O.C. Snead Ethanol potentiates the toxic effects of 1,4-butanediol Alcohol., Clin. Exp. Res. 9 1985 493 497
30. L.S. Quang, M.C. Desai, J.C. Kraner, M.W. Shannon, A.D. Woolf, and T.J. Maher Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice Ann. N. Y. Acad. Sci. 965 2002 461 472
31. R.H. Roth, and N.J. Giarman Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate Biochem. Pharmacol. 17 1968 735 739
32. K.J. Varner, B.A. Ogden, J. Delcarpio, and S. Meleg-Smith Cardiovascular responses elicited by the "binge" administration of methamphetamine J. Pharmacol. Exp. Ther. 301 2002 152 159